Biostage (OTCMKTS:BSTG – Get Free Report) and Nevro (NYSE:NVRO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Institutional and Insider Ownership 90.5% of Nevro shares are […]
Nevro (NYSE:NVRO – Free Report) had its price target reduced by Citigroup from $24.00 to $21.00 in a research report report published on Monday morning, Marketbeat.com reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other brokerages have also recently issued reports on NVRO. Truist Financial lowered their […]
Nevro Announces Participation in Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Royal Bank of Canada reissued their outperform rating on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $33.00 target price on the medical equipment provider’s stock. A number of other equities research analysts have also recently commented on NVRO. StockNews.com […]
Nevro (NYSE:NVRO) Research Coverage Started at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.